Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.
暂无分享,去创建一个
Y. Lévy | F. Collin | C. Leport | G. Chêne | J. Molina | C. Goujard | M. Bentata | M. Lafaurie | M. Garré